ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

White Heads NIH Legislative Policy Office

March 5, 2010

Whole Brain Radiation Raises Risk Of Memory Problems

September 26, 2008

ASBMT Installs New Officers

March 14, 2003

Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions

November 4, 1983

Scientists Lobby For Funding Increase. DuBois To Leave Vanderbilt For M.D. Anderson.

January 12, 2007

Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer

October 4, 1996